Aquestive Therapeutics, Inc. (AQST) Gross margin 2019–2025
Aquestive Therapeutics, Inc. (AQST) gross margin by fiscal year — reported gross profit divided by reported revenue.
58.3%FY2025 · since FY2019: 61.3% → 58.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 58.3% | -10.6 pp |
| FY2024 | 69.0% | +10.1 pp |
| FY2023 | 58.8% | -0.5 pp |
| FY2022 | 59.3% | — |
| FY2020 | 71.7% | +10.4 pp |
| FY2019 | 61.3% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice